about
Platelet distribution width as the prognostic marker in coronary bifurcation treatment.Transcatheter aortic valve implantation complicated by acute pericardial tamponade.Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathyA randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis.Comparison of dedicated BIOSS bifurcation stents with regular drug-eluting stents for coronary artery bifurcated lesions: Pooled analysis from two randomized studies.Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty - case report and review of the literature.Bioresorbable vascular scaffolds-what does the future bring?BiOSS LIM C: thin-strut cobalt-chromium version of the dedicated bifurcation stent.Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011.Is it possible to further improve clinical results with coronary bifurcation stenting, or what is more important - the technique or the stent?The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland.Impella LD microaxial pump supporting combined mitral and coronary surgery in a patient with dilated cardiomyopathy. A short bridge to recovery?Extension distance mismatch--an unrecognized factor for suboptimal side branch ostial coverage in bifurcation lesion stenting.Patient with ST-elevation myocardial infarction, coronary artery embolism and no signs of coronary atherosclerosis in angiography.The carina angle-new geometrical parameter associated with periprocedural side branch compromise and the long-term results in coronary bifurcation lesions with main vessel stenting only.Stenting below-the-knee bifurcations with dedicated bifurcation stent BiOSS Lim - first in man case report.Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study.Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model.Clinical verification of a theory for predicting side branch stenosis after main vessel stenting in coronary bifurcation lesions.Ulnar artery as access site for cardiac catheterization: anatomical considerations.First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C - 3-month results.Viral heart disease and acute coronary syndromes - often or rare coexistence ?An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.Assessment of vascular response to BiOSS LIM C® stents vs Orsiro® stents in the porcine coronary artery model.Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction.Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study.The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experience.Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry.Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society….Advances in mechanisms and treatment options of MINOCA caused by vasospasm or microcirculation dysfunction.Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter, randomized trial results.Prediction of troponin elevation by means of intracoronary electrocardiogram during percutaneous coronary intervention of coronary bifurcation lesions (from COronary SIde Branch Residual IschemiA and COllateralization Assessment Study; COSIBRIA & CoFirst-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.Self-positioning properties of dedicated bifurcation coronary stent BiOSS LIM® in the eye of 3D optical coherence tomography.Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry.Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial.Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.
P50
Q33442212-EA1A4D74-F20C-43FF-96DB-27B6D9AFE6B5Q33555482-39D5D581-7F03-4E45-AEC8-5A68102F6745Q35567348-74B75091-5EF9-442B-B2B0-7670178A77DDQ35807370-F43C4496-BD19-4E2C-8227-ECCED7D08D5AQ35843028-B04178C2-F75E-4421-A9AE-D417B7156E30Q38608665-8A7FA116-219F-4A2D-B88A-51476F6E6D42Q38671858-D35B0F2D-4D16-405D-A436-ED7225BB418DQ38822091-23C20BB6-E20A-4EED-9200-67B70E545556Q38844452-9819F609-7EC9-4B4C-98E0-E37FCB5BF76BQ39033674-50A7B708-44DE-490E-970B-4A95C1F6B7C8Q39138170-D22D0AAC-712A-4966-9DE5-5767797F154AQ40094838-449D8548-D322-4E33-ADC2-649DAD3F52B2Q41016389-4AFF6DAC-DBD0-4435-B954-C1BD961064DAQ42120521-FBDC776E-9E6F-4AA5-8D91-470AD270385EQ42966007-66B2A8FA-C381-4583-AB49-F14EA41E9BFCQ43128797-149E64BE-144A-4782-991C-68DA652C4D73Q43287135-73DCED53-C232-4D94-AC80-A3178540B034Q44215230-AF66B941-8539-4CFD-9E80-763A004CC76DQ44258091-CD32E5FE-5071-4CCC-97D3-03ABC5B83C10Q44411379-3E12EB8A-5D86-4E66-B3CD-C472FE22E793Q46115585-FAF4AABC-3572-488E-85B8-B64B6FECD778Q46273397-8C93BA13-0275-490A-AF0D-722077594D5BQ46845918-DCE36ED3-2B82-480A-BE27-68F4BE13EA68Q47296316-DA5F3E33-9BE0-43B0-8501-A52B7DDE5770Q47560039-17D1F91B-4B0F-45F4-9BA0-E3CDF41156FCQ48191598-C6E80DB8-15F9-4D6F-83E9-6FE9F07EF1E4Q48257878-49F3E51C-9F04-4AE4-AA8E-E8E4561B856DQ48300922-E6F04FF7-F6FD-4AE0-9F20-4D8F6E8BD48BQ48719993-2F57334E-DE3B-400F-8DB1-A951D9FD5137Q48794206-38EB9568-5FA3-43C4-A41D-D98F0DEB9DBDQ48932983-7BBBBC17-8C44-4F55-B058-B1440D9FA324Q50140004-EECCB0F3-7388-49AE-9209-591EDA2638C2Q50141491-A090EEF1-D450-4B56-84CD-6D2596CC03D7Q50905068-6F9AC178-D87C-4EC3-A465-6D3D8FCC9C56Q50905184-AEADBB2D-B14D-4C0C-B40F-5E21A9B99FD1Q51007425-F0F6297E-2087-470D-8AD8-3AF23BF90508Q51037923-621DEEE1-79CD-4C9A-94A7-656ED488E482Q51590905-24A8270C-8F00-4E9A-9824-A34147EB02F8Q51632179-20EFB359-96B8-43B5-9182-CE6E2182EA88Q51743381-C10519FC-B1DA-43D4-A0B2-8391761B1159
P50
description
researcher
@en
wetenschapper
@nl
name
R Gil
@en
R Gil
@nl
type
label
R Gil
@en
R Gil
@nl
prefLabel
R Gil
@en
R Gil
@nl
P106
P31
P496
0000-0002-9041-3313